Computational analysis artifacts linked to analyses and knowledge graph entities
How does mitochondrial dysfunction drive neurodegeneration across AD, PD, and ALS? Characterize PINK1/Parkin mitophagy pathway, mtDNA damage, ETC complex activity, and ROS generati
How does misfolded tau spread through the brain in tauopathies? Characterize prion-like propagation mechanisms, cell-to-cell transfer, and the role of MAPT mutations, ApoE genotype
Comprehensive single-cell analysis of Alzheimer's disease using Seattle Alzheimer's Disease Brain Cell Atlas data. Includes gene expression heatmaps, differential expression analys
Hypothesis ID: h-seaad-v4-26ba859b | Composite Score: 0.82/1.00
Hypothesis ID: h-seaad-51323624 | Composite Score: 0.73/1.00
The debate highlighted TFEB's role in mitochondrial-lysosomal coupling but couldn't resolve causation vs correlation. This distinction is critical for determining whether TFEB should be therapeuticall
**Analysis ID:** `sda-2026-04-01-gap-010` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `SDA-2026-04-11-gap-debate-20260410-111558-f9487fea` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-008` **Domain:** neurodegeneration **Status:** completed
The abstract notes that clinical presentations overlap across different myelopathy etiologies, but the mechanistic basis for this convergent phenotype is not explained. Resolving this could improve di
> *Investigate mechanistic links between early microglial priming states, neuroinflammatory signaling, and downstream neurodegeneration in preclinical and prodromal AD.*
**Analysis ID:** `gba-pd` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-013` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-auto-fd6b1635d9` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `SDA-2026-04-03-gap-crispr-neurodegeneration-20260402` **Domain:** Neurodegeneration **Research Question:** Evaluate the potential of CRISPR/Cas9 and related gene-editing technologies
**Analysis ID:** `sda-2026-04-01-gap-011` **Domain:** neurodegeneration **Status:** completed
What genes, pathways, and mechanisms are shared between age-dependent changes in the mouse brain and cell-type-specific vulnerabilities in human Alzheimer's disease? How does aging serve as a mechanis
How do peripheral immune system alterations influence CNS pathology and neurodegeneration in Alzheimer disease? Examine: (1) peripheral monocyte/macrophage trafficking across the blood-brain barrier,
The debate mentioned gene expression profiling but did not specify which neural cell populations (neurons, microglia, astrocytes, oligodendrocytes) exhibit the most pronounced alterations. This cellul
**Analysis ID:** `sda-2026-04-01-001` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `SDA-2026-04-04-gap-senescent-clearance-neuro` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-20260401-225149` **Domain:** neurodegeneration **Status:** completed
The paper describes memory-based migration routes maintained across generations but doesn't explain the neural substrate for this long-term spatial memory storage and transmission. This represents a m
Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia subtypes (DAM, homeostatic, inflammatory), astrocyte reactivity states, T-cell infiltration. Anchor to existing TREM2 (h-
**Analysis ID**: SDA-2026-04-03-gap-seaad-v4-20260402065846 **Quest**: Demo Showcase (Quest 16) — D16.2 **Date**: 2026-04-03 **Status**: Completed (4-round multi-agent debate)
**Analysis ID:** `SDA-2026-04-03-gap-seaad-20260402025452` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-v2-68d9c9c1` **Date:** 2026-04-02 **Domain:** neurodegeneration **Primary Cell Type:** Motor_Neurons **Hypotheses Generated:** 7 **Knowledge Graph Edges:** 20 ###
**Analysis ID:** `sda-2026-04-01-gap-014` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-002` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-v2-bc5f270e` **Domain:** neurodegeneration **Status:** completed
> What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? > Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. > Produce hypotheses
**Analysis ID:** `SDA-2026-04-04-frontier-lipidomics-dcdbc360` **Domain:** neurodegeneration **Status:** completed
What cell types are most vulnerable in Alzheimer's Disease based on SEA-AD transcriptomic data from the Allen Brain Cell Atlas? Identify mechanisms of cell-type-specific vulnerability in neurons, micr
**Analysis ID:** `sda-2026-04-01-gap-007` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-005` **Date:** 2026-04-02 **Domain:** neurodegeneration **Primary Cell Type:** Astrocytes **Hypotheses Generated:** 7 **Knowledge Graph Edges:** 20 ### Key Hypothe
Investigate mechanisms of epigenetic reprogramming in aging neurons, including DNA methylation changes, histone modification dynamics, chromatin remodeling, and partial reprogramming approaches (e.g.,
The debate identified vesicle accessibility as a major concern for nanobody approaches but provided no evidence for selective membrane penetration. This technical barrier could invalidate the entire n
**Analysis ID:** `sda-2026-04-01-gap-v2-18cf98ca` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-003` **Domain:** neurodegeneration **Status:** completed
While APOE4 disrupts microglial metabolism broadly, the debate didn't identify which specific disrupted pathways offer the best therapeutic targets. This prioritization is needed for focused drug deve
**Analysis ID:** `SDA-2026-04-04-gap-neuroinflammation-microglial-20260404` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `SDA-2026-04-03-26abc5e5f9f2` **Domain:** neuroscience **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-v2-691b42f1` **Domain:** neurodegeneration **Status:** completed
The debate highlighted broad cellular toxicity of existing HSP inhibitors but did not resolve how to engineer selectivity for tau-associated chaperones. This structure-activity relationship gap preven
What are the cell-type specific vulnerability mechanisms in Alzheimer's disease based on SEA-AD single-cell data?
The debate mentioned tau PTM targeting but did not identify which modifications are both disease-specific and accessible for therapeutic intervention. This knowledge gap limits the development of PTM-
What are the critical protein expression changes and post-translational modifications (phosphorylation, ubiquitination, glycosylation) at the aging synapse that drive early Alzheimer disease pathophys
**Analysis ID:** `SDA-2026-04-04-gap-tau-prop-20260402003221` **Date:** 2026-04-02 **Domain:** neurodegeneration **Primary Cell Type:** Microglia **Hypotheses Generated:** 7 **Knowledge Graph Edges:**
**Analysis ID:** `sda-2026-04-01-gap-006` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-9137255b` **Date:** 2026-04-02 **Domain:** neurodegeneration **Primary Cell Type:** Neurons **Hypotheses Generated:** 7 **Knowledge Graph Edges:** 20 ### Key Hypot
**Analysis ID:** `sda-2026-04-01-gap-004` **Domain:** neurodegeneration **Status:** completed
The debate revealed conflicting estimates ranging from <5% to 20% for FcRn's role in BBB transport, with species differences unresolved. This fundamental uncertainty undermines rational design of FcRn
**Analysis ID:** `sda-2026-04-01-gap-20260401231108` **Date:** 2026-04-02 **Domain:** neurodegeneration **Primary Cell Type:** Astrocytes **Hypotheses Generated:** 7 **Knowledge Graph Edges:** 20 ###
**Analysis ID:** `sda-2026-04-01-gap-v2-89432b95` **Domain:** neurodegeneration **Status:** completed
How do structural and functional connectivity changes in the human brain connectome drive cognitive decline in Alzheimer disease? Investigate: (1) default mode network disruption and amyloid depositio
**Analysis ID:** `gut-brain-ad` **Domain:** neurodegeneration **Status:** completed
The debate proposed targeting vesicle surface glycans but acknowledged no published data demonstrates unique glycosylation patterns on tau-containing vesicles. This fundamental question must be resolv
**Analysis ID:** `sda-2026-04-01-gap-012` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-v2-ee5a5023` **Domain:** neurodegeneration **Status:** completed
**Analysis ID:** `sda-2026-04-01-gap-009` **Domain:** neurodegeneration **Status:** completed